GBT Announces Participation in Upcoming Investor Conferences
May 06 2021 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today
announced that it will participate in virtual fireside chats at the
following investor conferences:
- Bank of America 2021 Healthcare Conference on May 12 at 4:15
p.m. ET; and
- RBC Capital Markets Global Healthcare Conference on May 19 at
3:05 p.m. ET.
The fireside chats will be webcast live from GBT’s website
at www.gbt.com in the Investors section. Replays of the
webcasts will be archived and available for one month following
each event.
About Global Blood Therapeutics
Global Blood Therapeutics (GBT) is a biopharmaceutical
company dedicated to the discovery, development, and delivery of
life-changing treatments that provide hope to underserved patient
communities. Founded in 2011, GBT is delivering on its goal to
transform the treatment and care of sickle cell disease (SCD), a
lifelong, devastating inherited blood disorder. The company has
introduced Oxbryta® (voxelotor) tablets, the first
FDA-approved treatment that directly inhibits sickle hemoglobin
polymerization, the root cause of red blood cell sickling in SCD.
GBT is also advancing its pipeline program in SCD with inclacumab,
a P-selectin inhibitor in development to address pain crises
associated with the disease, and GBT021601 (GBT601), the company’s
next generation hemoglobin S polymerization inhibitor. In addition,
GBT’s drug discovery teams are working on new targets to develop
the next wave of treatments for SCD. To learn more, please
visit www.gbt.com and follow the company on
Twitter @GBT_news.
Contact:Steven Immergut
(media)650-410-3258simmergut@gbt.com
Courtney
Roberts (investors)650-351-7881croberts@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Sep 2023 to Sep 2024